Delivery Order SPE2DR25D2205-SPE2DR26F2A15
Award Date 2/5/26
Potential Completion Date 2/6/26
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $26,661.26 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for RINVOQ ER 15 mg tablets (30-count unit dose packaging). The order is issued under an Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. This vehicle supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for RINVOQ ER 30 mg tablets with a ceiling value of $25,151.53. The delivery order is issued under the DLA Troop Support Medical IDC, a comprehensive global pharmaceutical support vehicle valued up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 6, 2026. The order is firm fixed price with no set-aside.
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for RINVOQ ER 45 mg tablets (28-tablet unit of use) with a ceiling value of $7,483.54. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026, enabling supply of pharmaceutical products and medical supplies to military healthcare...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $11,243.34 for RINVOQ ER 15 MG tablets (30-count unit dose). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, PA. The ultimate...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $6,836.70 for RINVOQ ER 30 mg tablets (30-count). Place of performance is Conshohocken, PA. Ultimate completion date is February 6, 2026. The order was issued under firm fixed-price terms with no set-aside. Amerisourcebergen Drug Corp operates under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December...
- <p>The Defense Logistics Agency issued a $22,589.63 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for supply of RINVOQ ER 45 MG tablets (28-count units).</p> <p>Place of performance is Conshohocken, PA. The order ceiling value is $22,589.63 with an ultimate completion date of February 6, 2026. Pricing is firm fixed price, and no set-aside was used.</p>
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $11,779.01 on November 18, 2025, for RINVOQ ER 15 mg tablets (30-count packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 19, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $90,294.60 for RINVOQ ER 45 mg tablets (28-count bottles).</p> <p>Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 6, 2026 and is priced on a firm fixed-price basis. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order valued at $15,076.40 to AmerisourceBergen Drug Corp on February 3, 2026, for the supply of RINVOQ ER 30 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order will be fulfilled at the company's Conshohocken, Pennsylvania location and is scheduled for completion by February 4, 2026. The contract carries no set-aside designation, indicating open competition among qualified vendors. This delivery order...
- The Defense Logistics Agency awarded a $16,527.62 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for RINVOQ ER 30 mg tablets (30-count units), with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F2A15Delivery Order
The Defense Logistics Agency issued a $24,161.48 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for RINVOQ ER 30 mg tablets (30-count bottles). The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 6, 2026. Pricing is firm fixed price with no set-aside.
Generated 5/6/26, 12:51 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 2/4/26 |